Literature DB >> 11819590

Protective effects of prostaglandin E1 on hepatocytes.

Xian-Ling Liu, Dai-Ming Fan.   

Abstract

Entities:  

Year:  2000        PMID： 11819590      PMCID： PMC4688744          DOI： 10.3748/wjg.v6.i3.326

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  15 in total

1.  Can alprostadil improve liver failure in HIV-infected patients with severe acute viral hepatitis?

Authors:  S Reus; M Priego; V Boix; D Torrús; J Portilla
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

2.  Indocyanine green disappearance enhanced by prostaglandin E1 in patients with hepatic resection.

Authors:  K Tsukada; T Sakaguchi; T Aono; D Ishizuka; N Fujita; K Hatakeyama
Journal:  J Surg Res       Date:  1996-11       Impact factor: 2.192

3.  Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats.

Authors:  P L Beck; G W McKnight; J K Kelly; J L Wallace; S S Lee
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

Review 4.  Severe acute hepatitis A associated with acute pure red cell aplasia.

Authors:  S Tomida; Y Matsuzaki; M Nishi; T Ikegami; T Chiba; M Abei; N Tanaka; T Osuga; Y Sato; T Abe
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

5.  Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease.

Authors:  M S Cattral; I Altraif; P D Greig; L Blendis; G A Levy
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

6.  [Treatment of patients with subfulminant forms of viral hepatitis B using prostaglandin E1].

Authors:  I Bojić; V Begović; P Mijusković
Journal:  Vojnosanit Pregl       Date:  1995 Sep-Oct       Impact factor: 0.168

7.  Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis.

Authors:  T Kurokawa; T Nonami; A Harada; A Nakao; S Sugiyama; T Ozawa; H Takagi
Journal:  Scand J Gastroenterol       Date:  1991-03       Impact factor: 2.423

8.  Inhibitory effects of prostaglandin E1 on T-cell mediated cytotoxicity against isolated mouse liver cells.

Authors:  M Ogawa; T Mori; Y Mori; S Ueda; H Yoshida; I Kato; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

9.  Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury.

Authors:  N Masaki; Y Ohta; H Shirataki; I Ogata; S Hayashi; S Yamada; K Hirata; S Nagoshi; S Mochida; T Tomiya
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  [Inhibitory effects of prostaglandin E1.alpha-cyclodextrin (PGE1.CD) on dimethylnitrosamine-induced acute liver damage in rats].

Authors:  A Suzuki; M Hagino; N Yasuda; K Sagawa; T Terawaki; M Ogawa; K Kondo; N Hamanaka; M Tanaka; Y Aze
Journal:  Nihon Yakurigaku Zasshi       Date:  1995-04
View more
  4 in total

Review 1.  Pharmacology of tetrandrine and its therapeutic use in digestive diseases.

Authors:  D G Li; Z R Wang; H M Lu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Effects of electroporation on primary rat hepatocytes in vitro.

Authors:  Yun-Qing Yao; Ding-Feng Zhang; Ai-Long Huang; Yun Luo; Da-Zhi Zhang; Bo Wang; Wei-Ping Zhou; Hong Ren; Shu-Hua Guo
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.

Authors:  Ying-Wei Xue; Qi-Fan Zhang; Zhi-Bing Zhu; Qi Wang; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic.

Authors:  Yuko Ono; Nozomi Ono; Kazuaki Shinohara
Journal:  Case Rep Emerg Med       Date:  2017-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.